Roquinimex
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- WO 2016/183486 Al 17 November 2016 (17.11.2016) P O P C T
- (12) United States Patent (10) Patent No.: US 6,596,770 B2 Lai Et Al
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2010/0055072 A1 Gant Et Al
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- (12) United States Patent (10) Patent No.: US 8,784.808 B2
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Clinical and Experimental Data on the Use of Laquinimod for the Treatment of Multiple Sclerosis
- Customs Tariff - Schedule Xxi - 1
- Australian Statistics on Medicines 2009
- Wo 2007/044693 A2
- Pdf/2009-10/Firmagon - Ct-6725.Pdf 58
- (12) United States Patent (10) Patent No.: US 9,724,338 B2 Michelson (45) Date of Patent: Aug
- WO 2017/125424 Al 27 July 2017 (27.07.2017) P O P C T
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al